Tech Company Financing Transactions
Trevi Therapeutics Funding Round
On 7/21/2017, Trevi Therapeutics announced $50.5 million in Series C funding from New Enterprise Associates, Aperture Venture Partners and Lundbeckfond Ventures.
Transaction Overview
New Enterprise Associates (Lead Investor) (Ed Mathers)
TPG Biotech (Eran Nadav)
Company Information
New Haven, CT 06510
USA
Management Team
Browse more venture capital transactions:
Prev: 7/21/2017: bioAffinity Technologies venture capital transaction
Next: 7/21/2017: NeuroVia venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs